Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD ; volume:102 ; number:12 ; day:10 ; month:10 ; year:2023 ; pages:3299-3309 ; date:12.2023
Annals of hematology ; 102, Heft 12 (10.10.2023), 3299-3309, 12.2023
- Creator
-
McBride, Helen J.
Frazer-Abel, Ashley
Thiemann, Sandra
Lehto, Sonya G.
Hutterer, Katariina M.
Liu, Jennifer
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-023-05439-4
- URN
-
urn:nbn:de:101:1-2024013013155074308375
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McBride, Helen J.
- Frazer-Abel, Ashley
- Thiemann, Sandra
- Lehto, Sonya G.
- Hutterer, Katariina M.
- Liu, Jennifer
- SpringerLink (Online service)
Other Objects (12)
Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data
Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Treating C3 glomerulopathy with eculizumab
Treating C3 glomerulopathy with eculizumab
Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data
Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Treating C3 glomerulopathy with eculizumab
Treating C3 glomerulopathy with eculizumab
Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data
Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Treating C3 glomerulopathy with eculizumab